<DOC>
	<DOCNO>NCT00925106</DOCNO>
	<brief_summary>The pharmacokinetics new formulation celecoxib evaluate . They expect provide favorable bioavailability characteristic present commercial formulation .</brief_summary>
	<brief_title>Pharmacokinetics Of Celecoxib Test Formulations</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Healthy male female volunteer Body weight BMI 17.530.5 Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurological , allergic disease Positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Bioavailability , pharmacokinetics , celecoxib</keyword>
</DOC>